Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A new mutation in the PLEC gene causes a rare condition with skin blistering, muscle weakness, and hair loss.

A specific combination of chemicals effectively expands genetically modified skin cells for potential use in skin therapy.

Combining negative pressure therapy with platelet-rich plasma speeds up healing and lowers death risk in diabetic foot ulcers.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Proper management and preventative measures can reduce serious adverse events from deoxycholic acid injections for fat reduction.

Zebrafish are useful for studying and developing treatments for human skin diseases.

People with Epidermolysis bullosa have many health problems including poor oral health, which is often neglected due to other medical issues.

Endocrine diseases in children often cause skin changes like dryness, redness, acne, hair loss, and more.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Higher concentration of botulinum toxin A is safe and effective for treating hair loss in men and women.

Different rheumatological diseases can cause specific skin problems.

Hair transplants can help transgender individuals match their appearance with their gender identity.

Type XVII collagen helps control skin cell growth and could be a target for anti-aging treatments.

Abnormal ECM and immune cell interactions can cause skin diseases.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Mutations in the KLHL24 gene cause skin blistering in epidermolysis bullosa simplex.

Type VII collagen absence helps skin development by allowing tissue remodeling.

Tissue engineering improves burn scar reconstruction by using skin substitutes and replacing damaged tissues.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

New skin repair methods show promise but need to be safer and more accessible.

Epidermal stem cells are vital for skin healing and have potential for treating skin disorders.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Lasers can trigger skin reactions, especially in darker skin, and more research is needed to improve treatments.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

DPCP can help regrow hair in some people with severe alopecia.

Long-term use of Risperidone may be linked to a serious skin condition in bipolar patients, affecting their overall well-being.